ETON jumped on a big earnings report a week ago. This small cap biotechology
company is making big money and traders responded. It has now experienced
a standard 0.5 Fib level retracement pullback and traders early in the jump
take profit. At this level new buyers have equilibrated with those selling their
shares and taking profit. The ZL MACD lines are...
VAXX is a speculative penny biotechnology NASDAQ stock with high volatility. On the 2H chart, it is currently trending up from a swing low
on April 25 with earnings to be reported Monday 5/8. May's relative volume compared with that of April is about 2-3X higher. To confirm
the bullish bias, VAXX is currently trading above its intermediate-term POC line on...
ACHV had good earnings in mid-March and has been in an ascending triangle since that time.
The uptrend had a correction April 17th to 20th to which buyers responded with spiking
buying volume. Current volume is 3x relative to the usual and customary historical volume
I will take a long trade on this when price descends to the support trendline...
ACHC previously ran up in a high tight flag pattern in my previous idea.
It has been slowly ascending in a narrowing channel. ( ascending wedge)
There has been a little push in volume on the indicator as price has
approached the upper boundaries of the channel. The average
directional index has decreased into the " chop zone" where consolidation
GOSS is a biotechnology penny stock without earnings valued based on future earnings
potential based on a "pipeline" which is subject to a long timeline of FDA regulation.
On the 30 minute chart. price is shown as being in the overvalued area in the upper VWAP
band and well above the POC line of the long-range volume profile. The RSI indicator is
As shown on the 15-minute chart, LABD is bouncing between stardard deviations of the VWAP in a 6% price range
fluctuation day to day. At the upper end it is reversing at the POC of the volume profile confluent with one
standard deviation above VWAP while at the bottom it is bouncing from the bottom of the lower high volume area
of the profile and two...
PBYI according to the recent earnings as no earnings nor revenue. This is typical in the biotechnology sector.
This 4H chart shows a consistent downtrend with a couple of minor pullback corrections shown with a Doji followed
by a green engulfing candle but with low volume and the K/D lines of the MACD did not on the histogram.
In the present, the volume pattern...
LABU a 3x leveraged EFT in the biotechnology sector has diverse holdings.
My thesis is that biotechnology and healthcare are relatively unhinged from the broader general market.
On this 15 minute chart, consolidation at support is seen in July, Price then rapidly rose
into a triple top in mid-August followed by a descent into a double bottom at...
from long consolidation then a pullback
now setup for entry
HOURLY CHART shows consolidation and
parabolic breakout with a pullback to
Awesome Indicator is supportive.
The catalyst was a good bear on earnings.